» Articles » PMID: 17287040

Three-dimensional Conformal Radiation May Deliver Considerable Dose of Incidental Nodal Irradiation in Patients with Early Stage Node-negative Non-small Cell Lung Cancer when the Tumor is Large and Centrally Located

Overview
Journal Radiother Oncol
Specialties Oncology
Radiology
Date 2007 Feb 9
PMID 17287040
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: To determine the dose to regional nodal stations in patients with T1-3N0M0 non-small cell lung cancer (NSCLC) treated with three-dimensional conformal radiation therapy (3DCRT) without intentional elective nodal irradiation (ENI).

Materials And Methods: Twenty-three patients with medically inoperable T1-3N0M0 NSCLC were treated with 3DCRT without ENI. Hilar and mediastinal nodal regions were contoured on planning CT. The prescription dose was normalized to 70 Gy. Equivalent uniform dose (EUD) and other dosimetric parameters (e.g., V40) were calculated for each nodal station.

Results: The median EUD for the whole group ranged from 0.4 to 4.4 Gy for all elective nodal regions. Gross tumor volume (GTV) and the relationship between GTV and hilum were significantly correlated with irradiation dose to ipsilateral hilar nodal regions (P<.05). For patients with GTV>or=30.2 cm3 (diameter approximately 4 cm) and or having any overlap with hilum, the median EUDs were 9.6, 22.6, and 62.9 Gy for ipsilateral lower paratracheal, subcarinal, and ipsilateral hilar regions, respectively. The corresponding median V40 were 32.5%, 39.3%, and 97.6%, respectively.

Conclusions: Although incidental nodal irradiation dose is low in the whole group, the dose to high-risk nodal regions is considerable in patients with T1-3N0 NSCLC when the primary is large and/or centrally located.

Citing Articles

The impact of target positioning error and tumor size on radiobiological parameters in robotic stereotactic radiosurgery for metastatic brain tumors.

Takizawa T, Tanabe S, Nakano H, Utsunomiya S, Sakai M, Maruyama K Radiol Phys Technol. 2022; 15(2):135-146.

PMID: 35257314 DOI: 10.1007/s12194-022-00655-5.


Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy.

Guo T, Zou L, Ni J, Chu X, Zhu Z Transl Lung Cancer Res. 2020; 9(5):2097-2112.

PMID: 33209629 PMC: 7653144. DOI: 10.21037/tlcr-20-511.


Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer.

Zhang N, Gu M, Wang J, Wu S Oncol Lett. 2020; 19(1):1042-1050.

PMID: 31897217 PMC: 6924155. DOI: 10.3892/ol.2019.11178.


Is a clinical target volume (CTV) necessary for locally advanced non-small cell lung cancer treated with intensity-modulated radiotherapy? -a dosimetric evaluation of three different treatment plans.

Xia F, Zhou L, Yang X, Chu L, Zhang X, Chu J J Thorac Dis. 2018; 9(12):5194-5202.

PMID: 29312726 PMC: 5757060. DOI: 10.21037/jtd.2017.10.147.


Efficacy of the smaller target volume for stage III non-small cell lung cancer treated with intensity-modulated radiotherapy.

Liang X, Yu H, Yu R, Xu G, Zhu G Mol Clin Oncol. 2015; 3(5):1172-1176.

PMID: 26623072 PMC: 4534841. DOI: 10.3892/mco.2015.588.